Abstracts

SAME SAME BUT DIFFERENT? RISK OF DAA THERAPY FAILURE IN REAL-LIFE HCV/HIV COINFECTION

Directly-acting agents (DAA) against HCV have impressively improved treatment of chronic hepatitis C coinfection. However, relapses still occur. Therefore we assessed the influence of traditional risk factors on treatment outcome in HCV/HIV coinfected patients in the German hepatitis C cohort (GECCO). The GECCO cohort is a multicenter cohort from 9 sites in Germany. All HCV/HIV…

DIRECT-ACTING ANTIVIRALS IMPROVE ACCESS TO CARE AND CURE FOR PATIENTS WITH HIV-HCV

Prior to the approval of direct-acting antivirals (DAA), uptake of curative hepatitis C virus (HCV) treatment was low, particularly for HIV/HCV co-infected patients. DAA offers >95% sustained virologic response (SVR) for the vast majority of HCV-infected patients, regardless of HIV-1 infection. Although safety and efficacy of HCV therapies have improved, challenges have emerged including high…

HIV AS A RISK FACTOR OF AIRWAY OBSTRUCTIVE DISEASE

We previously showed high prevalence of chronic obstructive pulmonary disease (COPD) in an all-smoking cohort of HIV-individuals. Whether COPD prevalence is higher in HIV-individuals than in the general population remains to be determined. The objective of this study was to compare the prevalence of airflow obstruction (AO) in HIV-individuals and in age and gender matched…

SUBOPTIMAL IMMUNE RECOVERY DESPITE SUPPRESSIVE ANTIRETROVIRAL THERAPY IN AFRICA

Suboptimal immune recovery (SO-IR), during suppressive antiretroviral therapy (ART), is associated with an increased risk of HIV-related illnesses, but has not been well-documented in African populations. We assessed SO-IR occurrence, defined by failure to attain clinically relevant thresholds of CD4 cell counts, factors associated with SO-IR, and incidence of tuberculosis (TB), AIDS or death during…

CURRENT STATIN USE REDUCES RISK OF VIRAL REBOUND ON SUPPRESSIVE CART

Pleiotropic effects of statins include improvement of endothelial dysfunction, increased nitric oxide, antioxidant and anti-inflammatory properties, and stabilization of atherosclerotic plaques. Statins are also active against HIV-1 in vitro; however, they have never been shown to have an antiviral effect in clinical studies. Given their short half-lives, a modest virologic effect of statins is difficult…

HIV-RELATED PILL AVERSION: CHARACTERIZING A NOVEL BARRIER TO ADHERENCE

Pill aversion, defined as difficulty swallowing pills without identifiable medical cause as well as anxiety associated with pill swallowing, is a poorly-characterized barrier to sustained viral suppression in HIV-infected adults. We aimed to determine the prevalence of pill aversion in an adult outpatient HIV population and describe the relationship between symptoms and skipping pills. This…